Background and Objectives: Staphylococcus aureus is one of the most common causes of morbidity and mortality among intensive care unit (ICU) patients. Nasal carriage is one of the main routs of S. aureus transmission between hospital personnel and patients. The objective of this study was to evaluate the efficacy of mupirocin ointment in eradication of nasal carriage of S. aureus in the ICU staff and patients of Panje-Azar hospital in Gorgan, Iran.
of great importance due to use of invasive devices, prolonged hospital stay, weakened immune system, and frequent consumption of antibiotics (1) . This study aimed to determine the efficiency of mupirocin ointment in eradication of S. aureus nasal carriage among the ICU staff and patients of Panje-azar hospital in Gorgan, Iran.
MATERIAL AND METHODS
This interventional study was performed on ICU staff and patients of Panjeazar teaching hospital during January-October 2014. The study received approval from the ethics committee of Golestan University of Medical Sciences (code: 509299302188). After obtaining necessary permission from the hospital authorities and written consent from the staff and family of patients, microbial culture of all samples from ICU patients were examined in the first three months of the study (January to March). Overall, 180 clinical samples were collected and cultured from 120 patients within 48 hours of admission to the hospital. Demographic data were recorded and studied for each patient. Samples found positive for S. aureus were recorded. S. aureus strains were detected by culture on mannitol salt agar and blood agar as well as biochemical testing according to standard guidelines (8) . In the next two months (April and May), sampling was done with sterile nasal swaps from 60 personnel working in the hospital ICU and new patients admitted in the last 24 hours. Positive cultures for S. aureus were treated with mupirocin ointment (2%) for five days according to the instructions (5) . To ensure about the eradication of S. aureus carriage, sampling was done after five weeks from the individuals treated with mupirocin and the patients who were admitted to the hospital since April 2014. Methicillin resistance was examined by disk diffusion method using cefoxitin disk (30µg, Himedia Co.) according to the Clinical and Laboratory Standards Institute guidelines (9) and using polymerase chain reaction (PCR) for presence of mecA gene as described by Louie et al (10) . The following MecA primer sequences (CinnaGen Co., Iran) were used for the PCR experiment: Forward: TCCAGATTACAACTTCACCAGG, Reverse: CCACTTCATATCTTGTAACG.
INTRODUCTION
Hospital-acquired infection is a global health problem associated with numerous factors. The etiological agents of these infections vary widely among different countries, but since 1980s, gram-positive bacteria especially Staphylococcus aureus have been considered as the main causative agent for nosocomial infections (1) . The habitat of S. aureus is the anterior nasal canal and about 20% of the human population is thought to be carriers of this microorganism (2) . The colonization rate of S. aureus in hospital staff is relatively higher than that in other individuals (3) . These individuals are in constant contact with patients in different wards, which might consequently affect the progression of infection in the patients (1) . The pathogenesis of S. aureus and its ability to acquire antimicrobial resistance have made this organism a major problem for hospitals and medical staff (3). S. aureus causes a wide range of infections including bacteremia, septicemia, pneumonia as well as skin, soft tissue and bone infections (4). Mupirocin is an ointment used for controlling staphylococcal infections in healthy carriers by inhibiting synthesis of isoleucyl-tRNA in the bacteria (5) . Twice daily administration of mupirocin nasal ointment (2%) for five days is the most effective treatment for methicillin-resistant S. aureus (MRSA) carriage. MRSA strains are important nosocomial pathogens that can cause potentially deadly diseases. The treatment of infections caused by MRSA strains has been challenging because of multiple-drug resistance (6) . Although vancomycin has been known as the antibiotic of choice for the treatment of infections caused by MRSA strains, studies from different parts of the world have recently reported the emergence of vancomycin-intermediate S. aureus (VISA) strains. The pathogenesis of MRSA and its increasing rate of resistance to antibiotics might prolong hospital stay, distress the patients and increase treatment costs. Hence, it is essential to take necessary measures for the control and prevention of MRSA infections (7). Since these microorganisms can easily spread in the hospital environment through respiratory secretions and contaminated hands, the most effective method of prevention is screening of nasal carriers among medical staff. Presence of S. aureus in the intensive care units (ICUs) is 50-year-old woman who was hospitalized due to cardiac arrest and was discharged after 20 days. During her stay, four samples were cultured and S. aureus was isolated from the sputum culture on the tenth day. The fifth case was a 62-year-old man who was admitted to the hospital due to a falling accident, and was discharged after 10 days. In this case, two samples were cultured and MRSA was isolated from the chest tube sample taken on the tenth day. Of the 60 nasal swab samples taken from the ICU staff, S. aureus was isolated only in seven samples (11.7%), two of which (22.2%) were identified as MRSA. Of the 120 nasal samples taken from the patients at admission, only two cases (1.6%) were identified as S. aureus but none was MRSA strain. Treatment with mupirocin eradicated S. aureus in all five carriers, as the post-treatment culture from the nasal carriers was negative after five weeks. However, the post-treatment culture was not performed for two patients because they had been discharged before the end of the fifth week. In the next stage of the study, the samples were taken from the patients three months after the intervention. Overall, 146 clinical samples (85 from men) were cultured and examined, which were mostly related to blood (11 specimens), urine (10 specimens) and chest tube (6 specimens) ( Table 2 ). The culture was positive for 35 cases (23.97%). Enterococcus, couagulase-negative Staphylococcus and yeast were the most common isolated microorganisms from the ICU patients. S. aureus was not isolated from any of the samples. There was no significant difference between the pre-and postintervention characteristics of the patients in the two groups. As shown in table 2, the treatment with mupirocin significantly reduced the frequency of Staphylococcus.
In the next three months (June to August), all cultures requested by the physician for the 120 ICU patients were examined and the results were recorded. The prevalence of S. aureus was determined in different periods and was later compared using chi-square test. P-values less than 0.05 were considered as statistically significant.
RESULTS
The most common reasons for hospital admission were car accidents (48.3%) and falling accident (10%). Level of consciousness in most patients was between 6 and 10 based on the Glascow Coma Scale. All patients were using urinary and venous catheters (Table1). Of 180 samples collected, 97 samples (53.9%) were culture-positive, which were mostly related to chest tubes (40 cases) and blood samples (20 cases) ( Table 2 ). Coagulasenegative staphylococci (16 cases), enterococci (15 cases), Escherichia (11 cases) and yeast (11 cases) were the most common organisms isolated. Of the 180 cultured samples from ICU patients in the first stage, S. aureus was isolated from five cases (2.8%, 2 men and 3 women), two of which were identified as MRSA (Figure 1) . One case was an 18-yearold woman who was admitted to the ICU because of suicide attempt and died after 23 days. The second case was a 23-year-old woman who was hospitalized in the ICU due to a car accident (head injury) and died after 18 days. In this case, three samples were cultured and S. aureus was isolated in the sputum sample taken on the second day of hospitalization. The third case was a 29-yearold man who was admitted to the hospital due to leg fracture and was discharged after 11 days. For this patient, three blood samples were taken and cultured, and S. aureus was isolated on the fourth day. The next case was a infection caused by S. aureus. This highlights that the infection control in the ICU has been satisfactory. Moreover, S. aureus was completely eradicated after the treatment with mupirocin nasal ointment. Two similar studies found the eradication rate of mupirocin to be 89.5% and 83.5% (18, 19) . A study claimed that 91% eradication rate could be achieved with twice-daily administration of mupirocin for five days (20) . Contrary to the previous studies, we completely eradicated nasal carriage of S. aureus using mupirocin ointment. The intervention was also successful in reducing the incidence of infection with S. aureus and other bacteria in the ICU. Of 120 patients admitted to the ICU during the threemonth assessment, 72 patients had at least one
DISCUSSION
In the present study, the initial frequency of S. aureus nasal carriage was 11.7% among the ICU staff, 3.3% of which were identified as MRSA strain. In study of Rahimi-Alang et al. on healthcare workers in Gorgan, the frequency of S. aureus and MRSA nasal carriage was 24% and 3%, respectively (11) . In study of Ruiz et al. in Ecuador, the prevalence of nasal carriage of MRSA among ICU staff was 2.4% (12). In some studies, the frequency of nasal carriage of S. aureus among hospital staff has been reported to be ranging between 11.9% and 33.28% (13-16). However, in a study in Iran, the prevalence of MRSA nasal carriage among a hospital's staff was 5.3% (17) . Before the intervention, of the 120 ICU patients, only five patients had hospital positive culture, while after the intervention, only 30 cases had positive culture results. This can be attributed to the greater hand hygiene adherence and better control of infection in the ICU. Our findings revealed that the prevalence of nasal carriage of S. aureus among ICU staff and patients was lower than that reported by other studies in Iran. Generally, the low prevalence of carriers in the ICU could be associated with the low number of nursing staff and the restrictions in this unit. Furthermore, no S. aureus was isolated after the treatment of the patients with mupirocin nasal ointment, indicating the high efficacy of the antibiotic in eradication of S. aureus carriage.
CONCLUSION
Compared to previous studies in Iran, the
